Preview Mode Links will not work in preview mode

Feb 23, 2026

Featuring an interview with Dr Terence Friedlander, including the following topics:

  • Perioperative durvalumab with neoadjuvant chemotherapy: Health-related quality-of-life outcomes in the NIAGARA trial (0:00)
  • Targeting HER2 in locally advanced or metastatic urothelial carcinoma (5:17)
  • TROP2-targeted antibody-drug conjugates for locally advanced or metastatic urothelial carcinoma (18:19)

CME information and select publications